Logo image of EMCG

EMBRACE CHANGE ACQUISITION C (EMCG) Stock Fundamental Analysis

USA - NASDAQ:EMCG - KYG3034H1092 - Common Stock

11 USD
-1.2 (-9.84%)
Last: 8/20/2025, 8:00:01 PM
Fundamental Rating

1

Taking everything into account, EMCG scores 1 out of 10 in our fundamental rating. EMCG was compared to 0 industry peers in the Unkown industry. EMCG may be in some trouble as it scores bad on both profitability and health. EMCG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EMCG had positive earnings in the past year.
EMCG had a negative operating cash flow in the past year.
In multiple years EMCG reported negative net income over the last 5 years.
In the past 5 years EMCG always reported negative operating cash flow.
EMCG Yearly Net Income VS EBIT VS OCF VS FCFEMCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1M -1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 3.96%
ROE 5.18%
ROIC N/A
ROA(3y)3.45%
ROA(5y)N/A
ROE(3y)4.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMCG Yearly ROA, ROE, ROICEMCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

EMCG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMCG Yearly Profit, Operating, Gross MarginsEMCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

EMCG has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, EMCG has a worse debt to assets ratio.
EMCG Yearly Shares OutstandingEMCG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
EMCG Yearly Total Debt VS Total AssetsEMCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

EMCG has an Altman-Z score of 1.97. This is not the best score and indicates that EMCG is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.04 indicates that EMCG is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACCN/A
EMCG Yearly LT Debt VS Equity VS FCFEMCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

EMCG has a Current Ratio of 0.02. This is a bad value and indicates that EMCG is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that EMCG may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
EMCG Yearly Current Assets VS Current LiabilitesEMCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for EMCG have decreased strongly by -31.03% in the last year.
EPS 1Y (TTM)-31.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 68.75, EMCG can be considered very expensive at the moment.
EMCG is valuated expensively when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 68.75
Fwd PE N/A
EMCG Price Earnings VS Forward Price EarningsEMCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMCG Per share dataEMCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EMCG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMBRACE CHANGE ACQUISITION C

NASDAQ:EMCG (8/20/2025, 8:00:01 PM)

11

-1.2 (-9.84%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-26 2025-08-26
Earnings (Next)11-03 2025-11-03
Inst Owners48.39%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap26.62M
Revenue(TTM)N/A
Net Income(TTM)1.05M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 68.75
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)0.16
EY1.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0
BVpS8.34
TBVpS8.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.96%
ROE 5.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.45%
ROA(5y)N/A
ROE(3y)4.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 1.97
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-250.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-250.5%
OCF growth 3YN/A
OCF growth 5YN/A

EMBRACE CHANGE ACQUISITION C / EMCG FAQ

Can you provide the ChartMill fundamental rating for EMBRACE CHANGE ACQUISITION C?

ChartMill assigns a fundamental rating of 1 / 10 to EMCG.


What is the valuation status of EMBRACE CHANGE ACQUISITION C (EMCG) stock?

ChartMill assigns a valuation rating of 0 / 10 to EMBRACE CHANGE ACQUISITION C (EMCG). This can be considered as Overvalued.


What is the profitability of EMCG stock?

EMBRACE CHANGE ACQUISITION C (EMCG) has a profitability rating of 1 / 10.


Can you provide the financial health for EMCG stock?

The financial health rating of EMBRACE CHANGE ACQUISITION C (EMCG) is 2 / 10.